Trends and outcomes after surgical lower limb revascularization in England

British Journal of Surgery

Volumn 98, Issue 10, 2011, Pages 1373-1382

  Moxey, P W ^a   Hofman, D ^b   Hinchliffe, R J ^a   Jones, K ^a   Thompson, M M ^a   Holt, P J E ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMPUTATION; ARTICLE; FEMALE; HUMAN; ISCHEMIA; LEG; MALE; MORTALITY; REOPERATION; REPERFUSION; RISK FACTOR; STATISTICS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED KINGDOM; VASCULAR SURGERY; VASCULARIZATION;

AGED; AMPUTATION; ENGLAND; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; REOPERATION; REPERFUSION; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 80052417816     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7547     Document Type: Article

References (35)

1. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Section D: chronic critical limb ischaemia. Eur J Vasc Endovasc Surg 2000; 19 (Suppl A): S144-S243.
2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, et al., Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 (Suppl S): S5-S67.
3. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al., Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366: 1925-1934.
4. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et al., Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010; 51 (Suppl): 5S-17S.
5. Moxey PW, Hofman D, Hinchliffe RJ, Jones K, Thompson MM, Holt PJ,. Epidemiological study of lower limb amputation in England between 2003 and 2008. Br J Surg 2010; 97: 1348-1353.
6. Wild S, Roglic G, Green A, Sicree R, King H,. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
7. Shaw JE, Sicree RA, Zimmet PZ,. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
8. NHS Information Centre for Health and Social Care. Linked ONS-HES Mortality Data. http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID= 1937&categoryID=1299 [accessed 1 August 2010].
9. Armitage JN, van der Meulen JH,; Royal College of Surgeons Co-morbidity Consensus Group. Identifying co-morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score. Br J Surg 2010; 97: 772-781.
10. Henke PK, Blackburn S, Proctor MC, Stevens J, Mukherjee D, Rajagopalin S, et al., Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg 2004; 39: 357-365.
11. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Namini H, Seely L,. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg 2005; 42: 456-464.
12. Muluk SC, Muluk VS, Kelley ME, Whittle JC, Tierney JA, Webster MW, et al., Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg 2001; 33: 251-257.
13. Gibson KD, Caps MT, Gillen D, Bergelin RO, Primozich J, Strandness DE Jr,. Identification of factors predictive of lower extremity vein graft thrombosis. J Vasc Surg 2001; 33: 24-31.
14. Renwick P, Johnson B, Wilkinson A, Galloway J, McCollum P,. Vascular Surgical Society of Great Britain and Ireland: limb outcome following failed femoropopliteal polytetrafluoroethylene bypass for intermittent claudication. Br J Surg 1999; 86: 693.
15. Aune S, Laxdal E,. Above-knee prosthetic femoropopliteal bypass for intermittent claudication. Results of the initial and secondary procedures. Eur J Vasc Endovasc Surg 2000; 19: 476-480.
16. Zayed H, Halawa M, Maillardet L, Sidhu PS, Edmonds M, Rashid H,. Improving limb salvage rate in diabetic patients with critical leg ischaemia using a multidisciplinary approach. Int J Clin Pract 2009; 63: 855-858.
17. Krishnan S, Nash F, Baker N, Fowler D, Rayman G,. Reduction in diabetic amputations over 11 years in a defined UK population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care 2008; 31: 99-101.
18. Jensen LP, Lepantalo M, Fossdal JE, Roder OC, Jensen BS, Madsen MS, et al., Dacron or PTFE for above-knee femoropopliteal bypass. A multicenter randomised study. Eur J Vasc Endovasc Surg 2007; 34: 44-49.
19. Solaković E, Totić D, Solaković S,. Femoro-popliteal bypass above knee with saphenous vein versus synthetic graft. Bosn J Basic Med Sci 2008; 8: 367-372.
20. Werneck CC, Lindsay TF,. Tibial angioplasty for limb salvage in high-risk patients and cost analysis. Ann Vasc Surg 2009; 23: 554-559.
21. Liistro F, Grotti S, Venturuzzo G, Angioli P, Turini F, Ducci K, et al., Clinical outcome of percutaneous revascularization by stent-assisted balloon angioplasty of femoropopliteal and tibial vessels in diabetic patients with critical limb ischemia. G Ital Cardiol (Rome) 2009; 10: 713-717.
22. Lu F, Zhang H, Shi YX, Zhang JW, Zhang BG,. The analysis of the follow-up results for the crural artery bypass. Zhonghua Wai Ke Za Zhi 2009; 47: 1175-1178.
23. de Latour B, Nourissat G, Duprey A, Berger L, Favre JP, Barral X,. Bypass to the perigeniculate collateral arteries: mid-term results. Eur J Vasc Endovasc Surg 2008; 35: 473-479.
24. Klinkert P, van Dijk PJ, Breslau PJ,. Polytetrafluoroethylene femorotibial bypass grafting: 5-year patency and limb salvage. Ann Vasc Surg 2003; 17: 486-491.
25. Gu YQ, Zhang J, Qi LX, Yu HX, Li JX, Li XF, et al., Surgical treatment of 82 patients with diabetic lower limb ischemia by distal arterial bypass. Chin Med J (Engl) 2007; 120: 106-109.
26. Mulaudzi TV, Robbs JV, Paruk N, Pillay B, Madiba TE, Govindsamy V,. The influence of diabetes on short-term outcome following a prosthetic above-the-knee femoro-popliteal bypass. Cardiovasc J Afr 2009; 20: 170-172.
27. Morris AD, McAlpine R, Steinke D, Boyle DI, Ebrahim AR, Vasudev N, et al., Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care 1998; 21: 738-743.
28. Wrobel JS, Mayfield JA, Reiber GE,. Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population. Diabetes Care 2001; 24: 860-864.
29. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G,. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009; 373: 2027-2033.
30. Putting feet first in diabetes. Lancet 2005; 366: 1674.
31. Department of Health. National Service Framework for Diabetes. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-4002951 [accessed 20 August].
32. Peltonen S, Biancari F, Lindgren L, Mäkisalo H, Honkanen E, Lepäntalo M,. Outcome of infrainguinal bypass surgery for critical leg ischaemia in patients with chronic renal failure. Eur J Vasc Endovasc Surg 1998; 15: 122-127.
33. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et al., Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg 2010; 51 (Suppl): 52S-68S.
34. Reddan DN, Marcus RJ, Owen WF Jr, Szczech LA, Landwehr DM,. Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients. Am J Kidney Dis 2001; 38: 57-63.
35. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et al., Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg 2010; 51 (Suppl): 18S-31S.